MK0782 + Low-Dose Aspirin 7-Day Erosion Endoscopy Study (0782-001)
This study will determine how if MK0782 is safe and tolerable and to determine how often and the severity of stomach and small intestine ulcers develop following administration of MK0782 plus enteric coated aspirin, rofecoxib 25mg plus enteric coated aspirin, naproxen 500 mg puls enteric coated asprin vs placebo.
This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Participant, Investigator)
Primary Purpose: Prevention
Please refer to this study by its ClinicalTrials.gov identifier: NCT00543868
|Study Director:||Medical Monitor||Merck Sharp & Dohme Corp.|